BioSpace News Archive

CARB-X announced today it is awarding Microbion Corporation of Bozeman, MT, USA, up to $6.1 million plus up to $5.4 million more if certain project milestones are met, to develop its anti-infective drug pravibismane for the treatment of cystic fibrosis (CF)-related pulmonary infections.

Themis, a company focused on vaccines and immune-modulation therapies for infectious diseases and cancer and MSD (trademark of Merck & Co., Inc., Kenilworth, N.J., USA, NYSE: MRK) today announced that the companies have entered into a definitive agreement under which MSD, through a subsidiary, will acquire privately-held Themis.

Arcus Biosciences, Inc. (NYSE:RCUS), a clinical-stage biopharmaceutical company focused on creating innovative cancer therapies, today announced the pricing of an underwritten public offering of 11,000,000 shares of its common stock at a price to the public of $27.50 per share

Veeva Systems Inc., a leading provider of industry cloud solutions for the global life sciences industry, announced results for its fiscal first quarter ended April 30, 2020.

Amedisys, Inc. (NASDAQ: AMED), one of America’s leading home health, hospice and personal care companies, today announced that Paul B. Kusserow, President and Chief Executive Officer will present at the 2020 Jefferies Virtual Healthcare Conference on Tuesday, June 2, 2020.

Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announces it has earned a $3 million milestone payment from Palvella Therapeutics as a result of Palvella raising $45 million in an oversubscribed Series C financing to leading biotechnology crossover and venture investors.

Senseonics Holdings, Inc., a medical technology company focused on the development and commercialization of the first and only long-term, implantable continuous glucose monitoring system for people with diabetes, announced that it plans to release its first quarter 2020 financial results after market close on Tuesday, June 9, 2020.

Convening national experts at the epicenter of vaccine development for COVID-19 while presenting critical conversations on the state of the biopharma industry amid the pandemic

LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that JJ Pellegrino, Chief Financial Officer, will present at the Jefferies Virtual Healthcare Conference on Thursday, June 4, 2020, at 2:00 PM EDT.

Merck (NYSE: MRK), known as MSD outside the United States and Canada, and Eisai today announced new data from analyses of two trials evaluating KEYTRUDA, Merck’s anti-PD-1 therapy, plus LENVIMA, an orally available multiple receptor tyrosine kinase inhibitor discovered by Eisai.